UTHR
United Therapeutics Corporation
Company Overview
| Mkt Cap | $18.78B | Price | $445.43 |
| Volume | 753.61K | Change | -1.79% |
| P/E Ratio | 15.7 | Open | $451.60 |
| Revenue | $2.9B | Prev Close | $453.53 |
| Net Income | $1.2B | 52W Range | $266.98 - $479.50 |
| Div Yield | N/A | Target | $486.15 |
| Overall | 78 | Value | 80 |
| Quality | 73 | Technical | 83 |
No chart data available
Stock Overview
Updated DailyUnited Therapeutics Corporation (UTHR) is a leading diversified company in the business industry, currently trading at $445.43 with a market capitalization of $18.78 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating strong quality characteristics with a MarketXLS quality score of 73.
Today's trading session shows UTHR with a volume of 754K shares. The stock opened down 0.43% from yesterday's close of $453.53. Current analyst estimates project earnings of $26.67 per share for this year, with next year targeting $27.98.
UTHR demonstrates very strong technical momentum based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including LLY, GILD, TEVA, PFE, BAX.
Key investment considerations for UTHR include strong overall investment metrics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 9.1%. The stock shows attractive valuation opportunity based on valuation analysis.
Analysis generated on November 3, 2025 at 07:17 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | UTHR | $445.43 | -1.8% | 753.61K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get United Therapeutics Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW